AbbVie Inc. revenue by year
Over the 10 fiscal years shown, revenue went from $25.64B (year ended Dec 31, 2016) to $61.16B (year ended Dec 31, 2025), a compound annual growth rate of 10.1%. The fastest growth was +37.7% in the year ended Dec 31, 2020; the weakest year was −6.4% (year ended Dec 31, 2023).
Annual revenue
| Fiscal year ended | Revenue (USD) | Change | XBRL concept | Reported in |
|---|---|---|---|---|
| Dec 31, 2025 | $61.16B | +8.6% | Revenues | 10-K filed Feb 20, 2026 |
| Dec 31, 2024 | $56.33B | +3.7% | Revenues | 10-K filed Feb 20, 2026 |
| Dec 31, 2023 | $54.32B | −6.4% | Revenues | 10-K filed Feb 20, 2026 |
| Dec 31, 2022 | $58.05B | +3.3% | Revenues | 10-K filed Feb 14, 2025 |
| Dec 31, 2021 | $56.20B | +22.7% | Revenues | 10-K filed Feb 20, 2024 |
| Dec 31, 2020 | $45.80B | +37.7% | Revenues | 10-K filed Feb 17, 2023 |
| Dec 31, 2019 | $33.27B | +1.6% | Revenues | 10-K filed Feb 18, 2022 |
| Dec 31, 2018 | $32.75B | +16.1% | Revenues | 10-K filed Feb 19, 2021 |
| Dec 31, 2017 | $28.22B | +10.1% | Revenues | 10-K filed Feb 21, 2020 |
| Dec 31, 2016 | $25.64B | +12.2% | Revenues | 10-K filed Feb 27, 2019 |
Quarterly revenue
Quarters reported in 10-Q filings. Fourth quarters are usually reported only inside the annual 10-K, so they are not listed separately here; we do not estimate them.
| Quarter | Revenue (USD) | vs same quarter a year earlier | Source |
|---|---|---|---|
| 3 months ended Sep 30, 2026 | $17.40B | +10.3% | 10-Q filed Nov 3, 2026 |
| 3 months ended Jun 30, 2026 | $16.99B | +10.2% | 10-Q filed Aug 3, 2026 |
| 3 months ended Mar 31, 2026 | $15.00B | +12.4% | 10-Q filed May 8, 2026 |
| 3 months ended Sep 30, 2025 | $15.78B | +9.1% | 10-Q filed Nov 3, 2026 |
| 3 months ended Jun 30, 2025 | $15.42B | +6.6% | 10-Q filed Aug 3, 2026 |
| 3 months ended Mar 31, 2025 | $13.34B | +8.4% | 10-Q filed May 8, 2026 |
| 3 months ended Sep 30, 2024 | $14.46B | +3.8% | 10-Q filed Nov 4, 2025 |
| 3 months ended Jun 30, 2024 | $14.46B | +4.3% | 10-Q filed Aug 4, 2025 |
Source: SEC EDGAR XBRL company facts for CIK 1551152 (raw data). Most recent filing in this dataset: 10-Q filed Nov 3, 2026. SEC data file dated Nov 3, 2026; page built Nov 5, 2026. Figures are as most recently reported, including restatements. How we select figures.